Clinical Study
Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI
| Variable | All |
| No. of men | 82 | Age, mean (SD), y | 62.0 (5.2) | PSA, median (IQR), μg/L | 6.6 (5.6–10.1) | Prostate volume, median (IQR), cm3 | 44.5 (31.8–59.3) | Men with lesion(s) on mpMRI, no. (%) | 58 (71) | Number of lesions on mpMRI, mean (SD) | 1.1 (0.9) | Patients with anterior lesions, no. (%) | 16 (20) | Index lesion score on mpMRIa, no. (%) | | PI-RADS 3 | 23 (28) | PI-RADS 4 | 14 (17) | PI-RADS 5 | 22 (27) | Tumor stagingb | | <T2 | 56 (68) | T2 | 15 (18) | T3 | 11 (13) | T4 | 0 (0) | Systematic biopsy cores per patient, mean (SD) | 12.1 (0.4) | Targeted biopsy cores per patient, mean (SD) | 2.2 (1.6) |
|
|
aHighest PI-RADS score. bClinical staging based on digital rectal examination.
|